Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe
Superior TAVI Valve Indicated for All Patients Diagnosed with Aortic Stenosis
IRVINE, Calif., Nov. 6, 2019 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for st... Devices, Interventional, Cardiology, Regulatory Edwards Lifesciences, SAPIEN 3, transcatheter, heart valve, aortic valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Aortic Stenosis | Cardiology | Heart | Heart Valve Disease | Heart Valves | Marketing | Pharmaceuticals